| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVET | Nexvet Biopharma plc | PAYNE JOHN BERNARD | Director | Jul 31, 2017 | Option Exercise | $6.72 | 10,800 | 72,576 | 0 | Aug 02, 2017, 09:40 PM | |
| NVET | Nexvet Biopharma plc | PAYNE JOHN BERNARD | Director | Jul 31, 2017 | Option Exercise | $6.72 | 6,195 | 41,630 | 0 | Aug 02, 2017, 09:40 PM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Jul 31, 2017 | Option Exercise | $6.72 | 16,400 | 110,208 | 0 | Aug 02, 2017, 09:38 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | Chief Financial Officer | Jul 31, 2017 | Option Exercise | $6.72 | 67,750 | 455,280 | 0 | Aug 02, 2017, 09:36 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | Chief Financial Officer | Jul 31, 2017 | Option Exercise | $6.72 | 21,239 | 142,726 | 0 | Aug 02, 2017, 09:36 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | Chief Financial Officer | Jul 31, 2017 | Option Exercise | $6.72 | 18,724 | 125,825 | 0 | Aug 02, 2017, 09:36 PM | |
| NVET | Nexvet Biopharma plc | Kilty Cormac G | Director | Jul 31, 2017 | Option Exercise | $6.72 | 155,164 | 1,042,702 | 0 | Aug 02, 2017, 09:34 PM | |
| NVET | Nexvet Biopharma plc | HORN JURGEN | Chief Product Development Ofcr | Jul 31, 2017 | Option Exercise | $6.72 | 15,750 | 105,840 | 0 | Aug 02, 2017, 09:32 PM | |
| NVET | Nexvet Biopharma plc | Heffernan Mark | Chief Executive Officer | Jul 31, 2017 | Option Exercise | $6.72 | 109,810 | 737,923 | 0 | Aug 02, 2017, 09:30 PM | |
| NVET | Nexvet Biopharma plc | Heffernan Mark | Chief Executive Officer | Jul 31, 2017 | Option Exercise | $6.72 | 243,587 | 1,636,905 | 0 | Aug 02, 2017, 09:30 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Jul 31, 2017 | Option Exercise | $6.72 | 16,020 | 107,654 | 0 | Aug 02, 2017, 09:27 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Jul 31, 2017 | Option Exercise | $6.72 | 1,500 | 10,080 | 0 | Aug 02, 2017, 09:27 PM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Jul 31, 2017 | Option Exercise | $6.72 | 42,600 | 286,272 | 0 | Aug 02, 2017, 09:25 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Jul 31, 2017 | Option Exercise | $6.72 | 18,980 | 127,546 | 0 | Aug 02, 2017, 09:22 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Jul 31, 2017 | Option Exercise | $6.72 | 33,180 | 222,970 | 0 | Aug 02, 2017, 09:22 PM | |
| NVET | Nexvet Biopharma plc | Brown Christopher Nigel | Director | Jul 31, 2017 | Option Exercise | $6.72 | 7,200 | 48,384 | 0 | Aug 02, 2017, 09:18 PM | |
| NVET | Nexvet Biopharma plc | Brown Christopher Nigel | Director | Jul 31, 2017 | Option Exercise | $6.72 | 8,800 | 59,136 | 0 | Aug 02, 2017, 09:18 PM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Jul 31, 2017 | Option Exercise | $6.72 | 13,580 | 91,258 | 0 | Aug 02, 2017, 04:09 PM | |
| NVET | Nexvet Biopharma plc | Paidipaty Ravi K | 10% Owner | Jul 31, 2017 | Option Exercise | $6.72 | 2,648,696 | 17,799,237 | 0 | Aug 02, 2017, 03:59 PM | |
| NVET | Nexvet Biopharma plc | Spokes Andrew J M | 10% Owner | Jul 31, 2017 | Option Exercise | $6.72 | 5,297,392 | 35,598,473 | 0 | Aug 02, 2017, 03:59 PM | |
| NVET | Nexvet Biopharma plc | NGP, L.L.C. | 10% Owner | Jul 31, 2017 | Option Exercise | $6.72 | 2,648,696 | 17,799,237 | 0 | Aug 02, 2017, 03:54 PM | |
| NVET | Nexvet Biopharma plc | Bushranger Funding, LLC | 10% Owner | Jul 31, 2017 | Option Exercise | $6.72 | 5,297,392 | 35,598,473 | 0 | Aug 02, 2017, 03:54 PM | |
| NVET | Nexvet Biopharma plc | PAYNE JOHN BERNARD | Director | Jul 01, 2017 | Option Exercise | $0.13 | 3,600 | 450 | 10,800 | Jul 05, 2017, 01:56 PM | |
| NVET | Nexvet Biopharma plc | Kilty Cormac G | Director | Jul 01, 2017 | Option Exercise | $0.13 | 3,600 | 450 | 10,800 | Jul 05, 2017, 01:51 PM | |
| NVET | Nexvet Biopharma plc | HORN JURGEN | Chief Product Development Ofcr | Jul 01, 2017 | Option Exercise | $0.13 | 15,750 | 1,969 | 15,750 | Jul 05, 2017, 01:39 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Jul 01, 2017 | Option Exercise | $0.13 | 12,340 | 1,543 | 18,980 | Jul 05, 2017, 01:30 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Jul 01, 2017 | Option Exercise | $0.13 | 2,866 | 358 | 26,986 | Jul 05, 2017, 01:30 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Jul 01, 2017 | Option Exercise | $0.13 | 6,194 | 774 | 33,180 | Jul 05, 2017, 01:30 PM | |
| NVET | Nexvet Biopharma plc | Brown Christopher Nigel | Director | Jul 01, 2017 | Option Exercise | $0.13 | 3,600 | 450 | 7,200 | Jul 05, 2017, 01:20 PM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Jul 01, 2017 | Option Exercise | $0.13 | 3,600 | 450 | 16,400 | Jul 05, 2017, 12:59 PM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Jun 30, 2017 | Option Exercise | $0.13 | 500 | 63 | 12,800 | Jul 05, 2017, 12:59 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Jun 30, 2017 | Option Exercise | $0.13 | 500 | 63 | 12,420 | Jul 05, 2017, 12:28 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Jul 01, 2017 | Option Exercise | $0.13 | 3,600 | 450 | 16,020 | Jul 05, 2017, 12:28 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | Chief Financial Officer | Jul 01, 2017 | Option Exercise | $0.13 | 34,000 | 4,250 | 67,750 | Jul 05, 2017, 12:18 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | Chief Financial Officer | Jul 01, 2017 | Option Exercise | $0.13 | 7,079 | 885 | 21,239 | Jul 05, 2017, 12:18 PM | |
| NVET | Nexvet Biopharma plc | Heffernan Mark | Chief Executive Officer | Jul 01, 2017 | Option Exercise | $0.13 | 60,643 | 7,580 | 109,810 | Jul 05, 2017, 12:11 PM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Jun 30, 2017 | Option Exercise | $0.13 | 500 | 63 | 9,980 | Jul 05, 2017, 12:00 AM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Jul 01, 2017 | Option Exercise | $0.13 | 3,600 | 450 | 13,580 | Jul 05, 2017, 12:00 AM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Jun 30, 2017 | Option Exercise | $0.13 | 500 | 63 | 39,000 | Jul 05, 2017, 12:00 AM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Jul 01, 2017 | Option Exercise | $0.13 | 3,600 | 450 | 42,600 | Jul 05, 2017, 12:00 AM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Mar 31, 2017 | Option Exercise | $0.13 | 500 | 63 | 12,300 | Apr 04, 2017, 11:23 AM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Mar 31, 2017 | Option Exercise | $0.13 | 500 | 63 | 11,920 | Apr 04, 2017, 11:20 AM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Mar 31, 2017 | Option Exercise | $0.13 | 500 | 63 | 38,500 | Apr 04, 2017, 11:16 AM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Mar 31, 2017 | Option Exercise | $0.13 | 500 | 63 | 9,480 | Apr 03, 2017, 02:03 PM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Dec 31, 2016 | Option Exercise | $0.13 | 500 | 63 | 8,980 | Jan 04, 2017, 10:57 AM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Dec 31, 2016 | Option Exercise | $0.13 | 500 | 63 | 11,800 | Jan 03, 2017, 07:38 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Dec 31, 2016 | Option Exercise | $0.13 | 500 | 63 | 11,420 | Jan 03, 2017, 07:34 PM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Dec 31, 2016 | Option Exercise | $0.13 | 500 | 63 | 38,000 | Jan 03, 2017, 07:29 PM | |
| NVET | Nexvet Biopharma plc | GEARING DAVID | Chief Scientific Officer | Nov 07, 2015 | Option Exercise | $0.13 | 9,203 | 1,150 | 292,266 | Nov 09, 2016, 12:13 PM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Sep 30, 2016 | Option Exercise | $0.13 | 500 | 63 | 11,300 | Oct 04, 2016, 03:52 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Sep 30, 2016 | Option Exercise | $0.13 | 500 | 63 | 10,920 | Oct 04, 2016, 03:47 PM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Sep 30, 2016 | Option Exercise | $0.13 | 500 | 63 | 37,500 | Oct 04, 2016, 03:44 PM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Sep 30, 2016 | Option Exercise | $0.13 | 500 | 63 | 8,480 | Oct 04, 2016, 09:26 AM | |
| NVET | Nexvet Biopharma plc | PAYNE JOHN BERNARD | Director | Jul 01, 2016 | Option Exercise | $0.13 | 3,600 | 450 | 7,200 | Aug 09, 2016, 04:47 PM | |
| NVET | Nexvet Biopharma plc | PAYNE JOHN BERNARD | Director | Jul 01, 2016 | Option Exercise | $0.13 | 3,600 | 450 | 3,600 | Jul 01, 2016, 09:25 PM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Jun 30, 2016 | Option Exercise | $0.13 | 500 | 63 | 7,200 | Jul 01, 2016, 09:15 PM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Jul 01, 2016 | Option Exercise | $0.13 | 3,600 | 450 | 10,800 | Jul 01, 2016, 09:15 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | Chief Financial Officer | Jul 01, 2016 | Option Exercise | $0.13 | 17,750 | 2,219 | 33,750 | Jul 01, 2016, 08:43 PM | |
| NVET | Nexvet Biopharma plc | Kilty Cormac G | Director | Jul 01, 2016 | Option Exercise | $0.13 | 3,600 | 450 | 7,200 | Jul 01, 2016, 08:29 PM | |
| NVET | Nexvet Biopharma plc | Heffernan Mark | Chief Executive Officer | Jul 01, 2016 | Option Exercise | $0.13 | 29,833 | 3,729 | 49,167 | Jul 01, 2016, 08:20 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Jun 30, 2016 | Option Exercise | $0.13 | 500 | 63 | 6,820 | Jul 01, 2016, 08:02 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Jul 01, 2016 | Option Exercise | $0.13 | 3,600 | 450 | 10,420 | Jul 01, 2016, 08:02 PM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Jun 30, 2016 | Option Exercise | $0.13 | 500 | 63 | 13,400 | Jul 01, 2016, 08:01 PM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Jul 01, 2016 | Option Exercise | $0.13 | 3,600 | 450 | 17,000 | Jul 01, 2016, 08:01 PM | |
| NVET | Nexvet Biopharma plc | GEARING DAVID | Chief Scientific Officer | Jul 01, 2016 | Option Exercise | $0.13 | 3,733 | 467 | 283,063 | Jul 01, 2016, 08:00 PM | |
| NVET | Nexvet Biopharma plc | GEARING DAVID | Chief Scientific Officer | Jul 01, 2016 | Option Exercise | $0.13 | 7,500 | 938 | 13,100 | Jul 01, 2016, 08:00 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Jul 01, 2016 | Option Exercise | $0.13 | 2,340 | 293 | 6,640 | Jul 01, 2016, 07:58 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Jul 01, 2016 | Option Exercise | $0.13 | 2,867 | 358 | 24,120 | Jul 01, 2016, 07:58 PM | |
| NVET | Nexvet Biopharma plc | Brown Christopher Nigel | Director | Jul 01, 2016 | Option Exercise | $0.13 | 3,600 | 468 | 3,600 | Jul 01, 2016, 07:55 PM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Jul 01, 2016 | Option Exercise | $0.13 | 3,600 | 450 | 7,980 | Jul 01, 2016, 11:34 AM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Jun 30, 2016 | Option Exercise | $0.13 | 500 | 63 | 4,380 | Jul 01, 2016, 11:29 AM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Mar 31, 2016 | Option Exercise | $0.13 | 500 | 63 | 12,900 | Apr 04, 2016, 07:12 PM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Mar 31, 2016 | Option Exercise | $0.13 | 500 | 63 | 6,700 | Apr 04, 2016, 06:58 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Mar 31, 2016 | Option Exercise | $0.13 | 500 | 63 | 6,320 | Apr 04, 2016, 06:48 PM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Mar 31, 2016 | Option Exercise | $0.13 | 500 | 63 | 3,880 | Apr 01, 2016, 11:46 AM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Mar 03, 2016 | Sale | $3.27 | 132 | 432 | 0 | Mar 17, 2016, 12:15 PM | |
| NVET | Nexvet Biopharma plc | GEARING DAVID | CHIEF SCIENTIFIC OFFICER | Mar 03, 2016 | Buy | $3.26 | 2,113 | 6,888 | 116,903 | Mar 07, 2016, 02:10 PM | |
| NVET | Nexvet Biopharma plc | GEARING DAVID | CHIEF SCIENTIFIC OFFICER | Mar 04, 2016 | Buy | $3.35 | 9,000 | 30,150 | 125,903 | Mar 07, 2016, 02:10 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Mar 02, 2016 | Buy | $3.20 | 1,500 | 4,800 | 1,500 | Mar 03, 2016, 08:12 PM | |
| NVET | Nexvet Biopharma plc | GEARING DAVID | Chief Scientific Officer | Feb 25, 2016 | Buy | $3.30 | 19,000 | 62,700 | 102,664 | Mar 01, 2016, 02:00 PM | |
| NVET | Nexvet Biopharma plc | GEARING DAVID | Chief Scientific Officer | Feb 26, 2016 | Buy | $3.34 | 12,126 | 40,501 | 114,790 | Mar 01, 2016, 02:00 PM | |
| NVET | Nexvet Biopharma plc | Kilty Cormac G | Director | Feb 24, 2016 | Buy | $3.17 | 3,000 | 9,525 | 144,364 | Feb 26, 2016, 05:41 PM | |
| NVET | Nexvet Biopharma plc | Roberts Thomas G. Jr. | 10% Owner | Feb 26, 2016 | Buy | $3.36 | 19,108 | 64,203 | 2,648,696 | Feb 26, 2016, 05:29 PM | |
| NVET | Nexvet Biopharma plc | Fisch Michael B. | 10% Owner | Feb 24, 2016 | Buy | $3.18 | 69,752 | 221,811 | 889,570 | Feb 26, 2016, 05:29 PM | |
| NVET | Nexvet Biopharma plc | Kim David T | 10% Owner | Feb 24, 2016 | Buy | $3.18 | 139,504 | 443,623 | 2,573,448 | Feb 26, 2016, 05:29 PM | |
| NVET | Nexvet Biopharma plc | Kim David T | 10% Owner | Feb 25, 2016 | Buy | $3.18 | 65,694 | 208,907 | 912,280 | Feb 26, 2016, 05:29 PM | |
| NVET | Nexvet Biopharma plc | Hirsch Daniel J. | 10% Owner | Feb 25, 2016 | Buy | $3.18 | 131,388 | 417,814 | 2,639,142 | Feb 26, 2016, 05:29 PM | |
| NVET | Nexvet Biopharma plc | FRIED RICHARD B | 10% Owner | Feb 26, 2016 | Buy | $3.36 | 9,554 | 32,101 | 915,583 | Feb 26, 2016, 05:29 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | Chief Financial Officer | Feb 18, 2016 | Buy | $3.22 | 5,000 | 16,099 | 18,724 | Feb 22, 2016, 07:43 PM | |
| NVET | Nexvet Biopharma plc | Gunn George W | Director | Dec 31, 2015 | Option Exercise | $0.13 | 500 | 63 | 12,400 | Jan 05, 2016, 07:26 PM | |
| NVET | Nexvet Biopharma plc | Hanna Ashraf | Director | Dec 31, 2015 | Option Exercise | $0.13 | 500 | 63 | 5,820 | Jan 05, 2016, 07:23 PM | |
| NVET | Nexvet Biopharma plc | McCracken Joseph S | Director | Dec 31, 2015 | Option Exercise | $0.13 | 500 | 63 | 6,200 | Jan 05, 2016, 07:21 PM | |
| NVET | Nexvet Biopharma plc | PATEL RAJIV A | Director | Dec 31, 2015 | Option Exercise | $0.13 | 500 | 63 | 3,380 | Jan 04, 2016, 12:22 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Nov 23, 2015 | Option Exercise | $0.13 | 4,300 | 538 | 21,253 | Nov 24, 2015, 04:19 PM | |
| NVET | Nexvet Biopharma plc | GEARING DAVID | Chief Scientific Officer | Nov 23, 2015 | Option Exercise | $0.13 | 5,600 | 700 | 279,330 | Nov 24, 2015, 03:57 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | CHIEF FINANCIAL OFFICER | Nov 23, 2015 | Option Exercise | $0.13 | 6,000 | 750 | 16,000 | Nov 24, 2015, 03:37 PM | |
| NVET | Nexvet Biopharma plc | Heffernan Mark | Chief Executive Officer | Nov 23, 2015 | Option Exercise | $0.13 | 7,250 | 906 | 19,334 | Nov 24, 2015, 03:12 PM | |
| NVET | Nexvet Biopharma plc | Heffernan Mark | Chief Executive Officer | Nov 20, 2015 | Option Exercise | $0.13 | 9,204 | 1,151 | 243,587 | Nov 20, 2015, 01:10 PM | |
| NVET | Nexvet Biopharma plc | Lismore Damian T. | Chief Financial Officer | Nov 17, 2015 | Option Exercise | $0.13 | 7,080 | 885 | 14,160 | Nov 19, 2015, 06:17 PM | |
| NVET | Nexvet Biopharma plc | Farrell Geraldine T | VP Operations, General Counsel | Nov 05, 2015 | Option Exercise | $0.13 | 6,195 | 774 | 16,953 | Nov 05, 2015, 02:07 PM |
Menu